These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36804450)

  • 1. A patient-centered nurse-supported primary care-based collaborative care program to treat opioid use disorder and depression: Design and protocol for the MI-CARE randomized controlled trial.
    DeBar LL; Bushey MA; Kroenke K; Bobb JF; Schoenbaum M; Thompson EE; Justice M; Zatzick D; Hamilton LK; McMullen CK; Hallgren KA; Benes LL; Forman DP; Caldeiro RM; Brown RP; Campbell NL; Anderson ML; Son S; Haggstrom DA; Whiteside L; Schleyer TKL; Bradley KA
    Contemp Clin Trials; 2023 Apr; 127():107124. PubMed ID: 36804450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.
    Campbell CI; Saxon AJ; Boudreau DM; Wartko PD; Bobb JF; Lee AK; Matthews AG; McCormack J; Liu DS; Addis M; Altschuler A; Samet JH; LaBelle CT; Arnsten J; Caldeiro RM; Borst DT; Stotts AL; Braciszewski JM; Szapocznik J; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Glass JE; Lapham GT; Murphy SM; Weinstein ZM; Yarborough BJH; Bradley KA
    Addict Sci Clin Pract; 2021 Jan; 16(1):9. PubMed ID: 33517894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative care in the treatment of opioid use disorder and mental health conditions in primary care: A clinical study protocol.
    Harris RA; Mandell DS; Kampman KM; Bao Y; Campbell K; Cidav Z; Coviello DM; French R; Livesey C; Lowenstein M; Lynch KG; McKay JR; Oslin DW; Wolk CB; Bogner HR
    Contemp Clin Trials; 2021 Apr; 103():106325. PubMed ID: 33631356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial.
    Wartko PD; Bobb JF; Boudreau DM; Matthews AG; McCormack J; Lee AK; Qiu H; Yu O; Hyun N; Idu AE; Campbell CI; Saxon AJ; Liu DS; Altschuler A; Samet JH; Labelle CT; Zare-Mehrjerdi M; Stotts AL; Braciszewski JM; Murphy MT; Dryden D; Arnsten JH; Cunningham CO; Horigian VE; Szapocznik J; Glass JE; Caldeiro RM; Phillips RC; Shea M; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Lapham GT; Addis M; Bradley KA; ; Ghiroli MM; Hamilton LK; Hu Y; LaHue JS; Loree AM; Murphy SM; Northrup TF; Shmueli-Blumberg D; Silva AJ; Weinstein ZM; Wong MT; Burganowski RP
    JAMA Intern Med; 2023 Dec; 183(12):1343-1354. PubMed ID: 37902748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
    Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
    Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods.
    Liebschutz JM; Subramaniam GA; Stone R; Appleton N; Gelberg L; Lovejoy TI; Bunting AM; Cleland CM; Lasser KE; Beers D; Abrams C; McCormack J; Potter GE; Case A; Revoredo L; Jelstrom EM; Kline MM; Wu LT; McNeely J
    Addict Sci Clin Pract; 2023 Nov; 18(1):70. PubMed ID: 37980494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State.
    Banta-Green CJ; Owens MD; Williams JR; Sears JM; Floyd AS; Williams-Gilbert W; Kingston S
    Addict Sci Clin Pract; 2022 Jul; 17(1):34. PubMed ID: 35799210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, parallel group, pragmatic comparative-effectiveness trial comparing medication-assisted treatment induction methods in primary care practices: The HOMER study protocol.
    Fernald DH; Nease DE; Westfall JM; Kwan BM; Dickinson LM; Sofie B; Lutgen C; Carroll JK; Wolff D; Heeren L; Felzien M; Zittleman L
    PLoS One; 2023; 18(9):e0290388. PubMed ID: 37682828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of a multisite randomized clinical trial examining an integrated behavioral treatment for veterans with co-occurring chronic pain and opioid use disorder: The pain and opioids integrated treatment in veterans (POSITIVE) trial.
    Vowles KE; Witkiewitz K; Clarke E; Schmidt Z; Borsari B; Edwards KE; Korecki JR; Moniz-Lewis DI; Bondzie JA; Mullins C; Thoreson CI; Delacruz J; Wilkins CH; Nelson S; Delventura J; Henderson R; Katz A; Hua W; Watson E; Baxley C; Canlas BR; Pendleton T; Herbst E; Batki S
    Contemp Clin Trials; 2023 Mar; 126():107096. PubMed ID: 36693589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
    D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
    Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians.
    Hooker SA; Crain AL; LaFrance AB; Kane S; Fokuo JK; Bart G; Rossom RC
    Addict Sci Clin Pract; 2023 Feb; 18(1):10. PubMed ID: 36774521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of CLARO (Collaboration Leading to Addiction Treatment and Recovery from other Stresses): A randomized trial of collaborative care for opioid use disorder and co-occurring depression and/or posttraumatic stress disorder.
    Meredith LS; Komaromy MS; Cefalu M; Murray-Krezan C; Page K; Osilla KC; Dopp AR; Leamon I; Tarhuni L; Hindmarch G; Jacobsohn V; Watkins KE;
    Contemp Clin Trials; 2021 May; 104():106354. PubMed ID: 33713840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motivational Interviewing as a tool to enhance access to mental health treatment in adolescents with chronic medical conditions and need for psychological support (COACH-MI): study protocol for a clusterrandomised controlled trial.
    Reinauer C; Viermann R; Förtsch K; Linderskamp H; Warschburger P; Holl RW; Staab D; Minden K; Muche R; Domhardt M; Baumeister H; Meissner T;
    Trials; 2018 Nov; 19(1):629. PubMed ID: 30428891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans.
    Petrakis I; Springer SA; Davis C; Ralevski E; Gu L; Lew R; Hermos J; Nuite M; Gordon AJ; Kosten TR; Nunes EV; Rosenheck R; Saxon AJ; Swift R; Goldberg A; Ringer R; Ferguson R
    Addict Sci Clin Pract; 2022 Jan; 17(1):6. PubMed ID: 35101115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics.
    Forray A; Mele A; Byatt N; Londono Tobon A; Gilstad-Hayden K; Hunkle K; Hong S; Lipkind H; Fiellin DA; Callaghan K; Yonkers KA
    PLoS One; 2022; 17(1):e0261751. PubMed ID: 35025898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial.
    Schramm ZA; Leroux BG; Radick AC; Ventura AS; Klein JW; Samet JH; Saxon AJ; Kim TW; Tsui JI
    Addict Sci Clin Pract; 2020 Jul; 15(1):30. PubMed ID: 32736660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blended smartphone intervention for patients in opioid maintenance treatment in Iran: protocol for a randomized controlled trial.
    Boumparis N; Noroozi A; Naghizadeh E; Meyer A; Wenger A; Rahimi-Movaghar A; Schaub MP
    BMC Psychiatry; 2023 Jul; 23(1):518. PubMed ID: 37464337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial.
    Bobb JF; Idu AE; Qiu H; Yu O; Boudreau DM; Wartko PD; Matthews AG; McCormack J; Lee AK; Campbell CI; Saxon AJ; Liu DS; Altschuler A; Samet JH; Northrup TF; Braciszewski JM; Murphy MT; Arnsten JH; Cunningham CO; Horigian VE; Szapocznik J; Glass JE; Caldeiro RM; Tsui JI; Burganowski RP; Weinstein ZM; Murphy SM; Hyun N; Bradley KA
    Drug Alcohol Depend; 2024 Aug; 261():111350. PubMed ID: 38875880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.
    D'Onofrio G; Edelman EJ; Hawk KF; Chawarski MC; Pantalon MV; Owens PH; Martel SH; Rothman R; Saheed M; Schwartz RP; Cowan E; Richardson L; Salsitz E; Lyons MS; Freiermuth C; Wilder C; Whiteside L; Tsui JI; Klein JW; Coupet E; O'Connor PG; Matthews AG; Murphy SM; Huntley K; Fiellin DA
    JAMA Netw Open; 2023 Apr; 6(4):e235439. PubMed ID: 37017967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a sequential multiple assignment randomized trial to test contingency management and an integrated behavioral economic and mindfulness intervention for buprenorphine-naloxone medication adherence for opioid use disorder.
    Peter SC; Murphy JG; Witkiewitz K; Hand SB; Thomas F; Johnson KC; Cowan R; Harris M; Derefinko KJ
    Trials; 2023 Mar; 24(1):237. PubMed ID: 36991453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.